What is the typical dosing schedule for the Vaxelis (diphtheria, tetanus, and pertussis, hepatitis B, poliovirus, and Haemophilus influenzae type b) vaccine for infants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vaxelis Dosing for Infants

Infants should receive 3 doses of Vaxelis vaccine administered at 2,4, and 6 months of age. 1

Standard Dosing Schedule

The primary vaccination series consists of exactly 3 doses given at ages 2,4, and 6 months. 1 This is the FDA-approved and ACIP-recommended schedule for routine infant immunization with Vaxelis (DTaP-IPV-Hib-HepB). 1

Key Timing Requirements

  • Minimum age for first dose: 6 weeks 1
  • Minimum interval between doses 1 and 2: 4 weeks 1
  • Minimum age for dose 2: 10 weeks 1
  • Minimum interval between doses 2 and 3: 4 weeks 1
  • Minimum age for dose 3: 24 weeks (approximately 6 months) 1
  • Maximum age for any dose: 4 years, 364 days (do not administer on or after the fifth birthday) 1

Critical Hepatitis B Consideration

Vaxelis is NOT licensed for the birth dose of hepatitis B vaccine. 1 Infants must receive a separate monovalent hepatitis B vaccine at birth, then Vaxelis can be used for subsequent doses starting at 6 weeks of age. 1

If the third dose of Vaxelis is inadvertently given before 24 weeks of age, an additional dose of hepatitis B vaccine must be given at age ≥24 weeks to complete the hepatitis B series. 1 This is because adequate immune response to hepatitis B requires the last dose to be administered at or after 24 weeks of age. 1

Maternal Hepatitis B Status Considerations

  • For infants born to HBsAg-negative mothers: Vaxelis can be used for the standard 3-dose series at 2,4, and 6 months (after birth dose of monovalent HepB). 1

  • For infants born to HBsAg-positive or unknown status mothers: Vaxelis can still be used for the 3-dose series, but these infants require monovalent hepatitis B vaccine plus HBIG within 12 hours of birth. 1 The third dose of Vaxelis should not be given before 24 weeks of age in these infants. 1

Important Limitations

Vaxelis should NOT be used for booster doses. 1 After completing the 3-dose primary series:

  • A separate DTaP vaccine is needed for the fourth dose at 15-18 months 1
  • A separate Hib conjugate vaccine is needed for the booster at 12-15 months 1
  • A separate IPV vaccine is needed for the fourth dose at 4-6 years 1

If Vaxelis is inadvertently given for a booster dose, the dose does not need to be repeated with another vaccine when proper spacing of previous doses is maintained. 1

Special Population: American Indian/Alaska Native Infants

Vaxelis does not have a preferential recommendation for AI/AN infants at this time. 1 This is because data on antibody response after the first dose in AI/AN infants are not currently available, and these infants historically benefit from early protection provided by PRP-OMP-containing Hib vaccines. 1

Common Pitfalls to Avoid

  • Do not use Vaxelis for the birth dose - this is a critical error that would leave the infant without timely hepatitis B protection. 1
  • Do not give the third dose before 24 weeks of age unless you plan to administer an additional hepatitis B vaccine dose at ≥24 weeks. 1
  • Do not use Vaxelis for catch-up schedules with accelerated 4-week intervals for the third dose, as this would violate the 24-week minimum age requirement. 1
  • Do not continue using Vaxelis beyond the primary series - switch to appropriate monovalent or combination vaccines for booster doses. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.